Abstract
The majority of the drugs currently employed in the treatment and prophylaxis of malaria are chiral and show enantioselective pharmacodynamic and pharmacokinetic properties in humans and animals. Thus, the assessment of the disposition of these enantiomers in the body using reliable and feasible methods is required to improve the therapy of this disease. Several methods devoted to the enantioselective analysis of the antimalarial drugs and their respective metabolites have been described. Therefore, this article intends to review the methods reported for the enantioselective determination of these analytes with a focus on biological matrices and particular attention will be given to the modern techniques of analysis and sample preparation.
Keywords: Antimalarial drugs, Enantioselective analysis, Sample preparation, Biological matrices
Current Pharmaceutical Analysis
Title: Enantioselective Analysis of Antimalarial Drugs and their Metabolites
Volume: 6 Issue: 1
Author(s): Igor R. Santos Magalhaes and Pierina S. Bonato
Affiliation:
Keywords: Antimalarial drugs, Enantioselective analysis, Sample preparation, Biological matrices
Abstract: The majority of the drugs currently employed in the treatment and prophylaxis of malaria are chiral and show enantioselective pharmacodynamic and pharmacokinetic properties in humans and animals. Thus, the assessment of the disposition of these enantiomers in the body using reliable and feasible methods is required to improve the therapy of this disease. Several methods devoted to the enantioselective analysis of the antimalarial drugs and their respective metabolites have been described. Therefore, this article intends to review the methods reported for the enantioselective determination of these analytes with a focus on biological matrices and particular attention will be given to the modern techniques of analysis and sample preparation.
Export Options
About this article
Cite this article as:
Santos Magalhaes R. Igor and Bonato S. Pierina, Enantioselective Analysis of Antimalarial Drugs and their Metabolites, Current Pharmaceutical Analysis 2010; 6 (1) . https://dx.doi.org/10.2174/157341210790780186
DOI https://dx.doi.org/10.2174/157341210790780186 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Efficacy of a Chitosan-curcumin Mixture in Treating Indomethacininduced Acute Gastric Ulcer in Rats
Current Pharmaceutical Biotechnology Recent Advances in Colon Drug Delivery Technology
Drug Delivery Letters The Use of Micro- and Nanoparticles in the Stabilisation of Pickering-Type Emulsions for Topical Delivery
Current Pharmaceutical Biotechnology Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Experimental Fracture Protocols in Assessments of Potential Agents for Osteoporotic Fracture Healing Using Rodent Models
Current Drug Targets Pathophysiology and Treatment of Diabetic Peripheral Neuropathy: The Case for Diabetic Neurovascular Function as an Essential Component
Current Diabetes Reviews The Plasma Coagulation Cascade: Potential Targets for Novel Anticoagulants in Major Lower Limb Surgery
Current Vascular Pharmacology Pharmaco-Therapeutic Challenges in Cancer Biology with Focus on the Immune- System Related Risk Factors
Current Pharmaceutical Design Blockade of Apoptosis by ACE Inhibitors and Angiotensin Receptor Antagonists
Current Pharmaceutical Design Block Copolymers for Drug Delivery Nano Systems (DDnSs)
Current Medicinal Chemistry Catastrophic Antiphospholipid Syndrome - 20 Years Later
Current Rheumatology Reviews A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Editorial (Thematic Issue: The Biological Approach to Advanced Cancer: Are We in the Middle of the Road?)
Current Drug Targets Psoriasin, A Multifunctional Player in Different Diseases
Current Protein & Peptide Science RNA Interference: A New Targeted Tumour Therapy?
Current Cancer Therapy Reviews Implications of Melatonin Therapy in Irritable Bowel Syndrome: A Systematic Review
Current Pharmaceutical Design Short Term Statin Treatment Improves Survival and Differentially Regulates Macrophage-Mediated Responses to Staphylococcus aureus
Current Pharmaceutical Biotechnology Plasmacytoid Dendritic Cells Count in Antiretroviral-Treated Patients is Predictive of HIV Load Control Independent of CD4+ T-Cell Count
Current HIV Research Adverse Drug Reactions and Safety Considerations of NSAIDs: Clinical Analysis
Current Drug Safety